Semaglutide Linked to Reduced Risk for Alzheimer Diagnosis in T2DM

FRIDAY, Nov. 1, 2024-- For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications, according to a study published online...